VivoSim Labs, Inc.

VivoSim Labs, Inc.verified

VIVS

Price:

$2.29

Market Cap:

$5.97M

VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Org...[Read more]

Industry

Biotechnology

IPO Date

2012-02-14

Stock Exchange

NASDAQ

Ticker

VIVS

The Current Ratio as of December 2025 (TTM) for VivoSim Labs, Inc. (VIVS) is 4.52

According to VivoSim Labs, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.52. This represents a change of 72.78% compared to the average of 2.62 of the last 4 quarters.

VivoSim Labs, Inc. (VIVS) Historical Current Ratio (quarterly & annually)

How has VIVS Current Ratio performed in the past?

The mean historical Current Ratio of VivoSim Labs, Inc. over the last ten years is 14.56. The current 4.52 Current Ratio has changed 3.00% with respect to the historical average. Over the past ten years (40 quarters), VIVS's Current Ratio was at its highest in in the March 2021 quarter at 53.26. The Current Ratio was at its lowest in in the December 2024 quarter at 0.72.

Quarterly (TTM)
Annual

Average

14.56

Median

10.58

Minimum

2.12

Maximum

53.26

VivoSim Labs, Inc. (VIVS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of VivoSim Labs, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 240.40%

Maximum Annual Current Ratio = 53.26

Minimum Annual Increase = -78.25%

Minimum Annual Current Ratio = 2.12

Quarterly (TTM)
Annual
YearCurrent RatioChange
20253.2553.40%
20242.12-54.43%
20234.64-78.25%
202221.35-59.90%
202153.26240.40%
202015.6551.57%
201910.322.82%
201810.04-7.30%
201710.83-23.61%
201614.1831.66%

VivoSim Labs, Inc. (VIVS) Average Current Ratio

How has VIVS Current Ratio performed in the past?

The current Current Ratio of VivoSim Labs, Inc. (VIVS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.34

5-year avg

16.92

10-year avg

14.56

VivoSim Labs, Inc. (VIVS) Current Ratio vs. Peers

How is VIVS’s Current Ratio compared to its peers?

VivoSim Labs, Inc.’s Current Ratio is greater than Quoin Pharmaceuticals, Ltd. (1.95), greater than Pasithea Therapeutics Corp. (4.02), less than Cyclerion Therapeutics, Inc. (5.78), greater than Alaunos Therapeutics, Inc. (2.92), less than PharmaCyte Biotech, Inc. (18.01), less than Polyrizon Ltd. (44.04), greater than NovaBay Pharmaceuticals, Inc. (2.85), greater than Radiopharm Theranostics Limited (3.37), greater than XTL Biopharmaceuticals Ltd. (0.61), greater than Impact BioMedical Inc. (0.06),

Build a custom stock screener for VivoSim Labs, Inc. (VIVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VivoSim Labs, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VivoSim Labs, Inc. (VIVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VivoSim Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is VivoSim Labs, Inc.'s Current Ratio?

How is the Current Ratio calculated for VivoSim Labs, Inc. (VIVS)?

What is the highest Current Ratio for VivoSim Labs, Inc. (VIVS)?

What is the 3-year average Current Ratio for VivoSim Labs, Inc. (VIVS)?

What is the 5-year average Current Ratio for VivoSim Labs, Inc. (VIVS)?

How does the current Current Ratio for VivoSim Labs, Inc. (VIVS) compare to its historical average?